{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:42:07Z","timestamp":1791859327598,"version":"4.3.4"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T00:00:00Z","timestamp":1584662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81401691"],"award-info":[{"award-number":["81401691"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81702030"],"award-info":[{"award-number":["81702030"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"DOI":"10.3389\/fcimb.2020.00118","type":"journal-article","created":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T04:49:31Z","timestamp":1584679771000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":31,"title":["Pharmacophore-Based Virtual Screening Toward the Discovery of Novel Anti-echinococcal Compounds"],"prefix":"10.3389","volume":"10","author":[{"given":"Congshan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhai","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqing","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haobing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,3,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1007\/s12272-017-0914-1","article-title":"QSAR based therapeutic management of M. Tuberculosis","volume":"40","author":"Ahamad","year":"2017","journal-title":"Arch. Pharm. Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/cbdd.13418","article-title":"Structure-based pharmacophore models to probe anticancer activity of inhibitors of protein kinase B-beta (PKB beta)","volume":"93","author":"Akhtar","year":"2018","journal-title":"Chem. Biol. Drug Des"},{"key":"B3","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s00894-018-3746-0","article-title":"Identification of new promising Plasmodium falciparum superoxide dismutase allosteric inhibitors through hierarchical pharmacophore-based virtual screening and molecular dynamics","volume":"24","author":"Araujo","year":"2018","journal-title":"J. Mol. Model."},{"key":"B4","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1002\/ardp.201500045","article-title":"Generated 3D-common feature hypotheses using the HipHop method for developing new topoisomerase I inhibitors","volume":"348","author":"Ataei","year":"2015","journal-title":"Arch. Pharm."},{"key":"B5","doi-asserted-by":"publisher","first-page":"180176","DOI":"10.1098\/rsos.180176","article-title":"Ligand-based pharmacophore model for the discovery of novel CXCR2 antagonists as anti-cancer metastatic agents","volume":"5","author":"Che","year":"2018","journal-title":"R. Soc. Open Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s11030-016-9724-5","article-title":"Pharmacophore-based screening and drug repurposing exemplified on glycogen synthase kinase-3 inhibitors","volume":"21","author":"Crisan","year":"2017","journal-title":"Mol. Divers."},{"key":"B7","first-page":"503","article-title":"Multicentre clinical trials of benzimidazole-carbamates in human cystic echinococcosis (phase 2)","volume":"67","author":"Davis","year":"1989","journal-title":"Bull. World Health Organ."},{"key":"B8","first-page":"383","article-title":"Multicentre clinical trials of benzimidazolecarbamates in human echinococcosis","volume":"64","author":"Davis","year":"1986","journal-title":"Bull. World Health Organ."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1007\/s00894-011-1187-0","article-title":"3D-QSAR based pharmacophore modeling and virtual screening for identification of novel pteridine reductase inhibitors","volume":"18","author":"Dube","year":"2012","journal-title":"J. Mol. Model."},{"key":"B10","volume-title":"WHO\/OIE Manual on Echinococcosis in Humans and Animals: A Public Health Problem of Global Concern.","author":"Eckert","year":"2001"},{"key":"B11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/0169-4758(95)80036-0","article-title":"Medical aspects of echinococcosis","volume":"11","author":"Eckert","year":"1995","journal-title":"Parasitol. Today"},{"key":"B12","doi-asserted-by":"publisher","first-page":"E959","DOI":"10.3390\/molecules22060959","article-title":"3D pharmacophore-based virtual screening and docking approaches toward the discovery of novel HPPD inhibitors","volume":"22","author":"Fu","year":"2017","journal-title":"Molecules"},{"key":"B13","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1080\/17460441.2017.1291628","article-title":"Applications of computer-aided approaches in the development of hepatitis C antiviral agents","volume":"12","author":"Ganesan","year":"2017","journal-title":"Expert Opin. Drug Discov."},{"key":"B14","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s10822-017-0028-3","article-title":"Multiple receptor-ligand based pharmacophore modeling and molecular docking to screen the selective inhibitors of matrix metalloproteinase-9 from natural products","volume":"31","author":"Gao","year":"2017","journal-title":"J. Comput. Aided Mol. Des."},{"key":"B15","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.biopha.2016.11.076","article-title":"Novel butyrylcholinesterase inhibitors through pharmacophore modeling, virtual screening and DFT-based approaches along-with design of bioisosterism-based analogues","volume":"85","author":"Gogoi","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"B16","doi-asserted-by":"publisher","first-page":"4721","DOI":"10.1080\/07391102.2018.1559098","article-title":"Pharmacophore-based virtual screening approach for identification of potent natural modulatory compounds of human Toll-like receptor 7","volume":"37","author":"Gupta","year":"2019","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B17","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.2174\/1381612822666160414142530","article-title":"Virtual screening techniques and current computational infrastructures","volume":"22","author":"Haga","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"B18","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1017\/S0022149X0928936X","article-title":"Alveolar and cystic echinococcosis: towards novel chemotherapeutical treatment options","volume":"83","author":"Hemphill","year":"2009","journal-title":"J. Helminthol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s11030-017-9745-8","article-title":"Identification of a novel putative inhibitor of the Plasmodium falciparum purine nucleoside phosphorylase: exploring the purine salvage pathway to design new antimalarial drugs","volume":"21","author":"Kagami","year":"2017","journal-title":"Mol. Divers."},{"key":"B20","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1007\/s00894-018-3820-7","article-title":"Receptor pharmacophore ensemble (REPHARMBLE): a probabilistic pharmacophore modeling approach using multiple protein-ligand complexes","volume":"24","author":"Kumar","year":"2018","journal-title":"J. Mol. Model."},{"key":"B21","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/0169-4758(90)90227-U","article-title":"Mode of action of benzimidazoles","volume":"6","author":"Lacey","year":"1990","journal-title":"Parasitol. Today"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B23","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.actatropica.2019.05.009","article-title":"The efficacy of an alternative mebendazole formulation in mice infected with Echinococcus multilocularis","volume":"196","author":"Liu","year":"2019","journal-title":"Acta Trop."},{"key":"B24","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.actatropica.2017.08.031","article-title":"In vitro effects of amino alcohols on Echinococcus granulosus","volume":"182","author":"Liu","year":"2018","journal-title":"Acta Trop."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1007\/s00436-015-4412-4","article-title":"In vivo and in vitro efficacies of mebendazole, mefloquine and nitazoxanide against cyst echinococcosis","volume":"114","author":"Liu","year":"2015","journal-title":"Parasitol. Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ijid.2008.03.037","article-title":"Echinococcosis: a review","volume":"13","author":"Moro","year":"2009","journal-title":"Int. J. Infect. Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"5146","DOI":"10.1128\/AAC.02113-13","article-title":"In vitro and in vivo effects of tamoxifen against larval stage Echinococcus granulosus","volume":"58","author":"Nicolao","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B28","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1023\/A:1021954728347","article-title":"A comparison of the pharmacophore identification programs: catalyst, DISCO and GASP","volume":"16","author":"Patel","year":"2002","journal-title":"J. Comput. Aided Mol. Des."},{"key":"B29","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1021\/acs.jcim.5b00680","article-title":"Identification of new human malaria parasite plasmodium falciparum dihydroorotate dehydrogenase inhibitors by pharmacophore and structure-based virtual screening","volume":"56","author":"Pavadai","year":"2016","journal-title":"J. Chem. Inf. Model."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1021\/ci100128k","article-title":"Discovery of new inhibitors of Schistosoma mansoni PNP by pharmacophore-based virtual screening","volume":"50","author":"Postigo","year":"2010","journal-title":"J. Chem. Inf. Model."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e0005618","DOI":"10.1371\/journal.pntd.0005618","article-title":"Development of a movement-based in vitro screening assay for the identification of new anti-cestodal compounds","volume":"11","author":"Ritler","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ijpddr.2018.06.004","article-title":"Activity of mefloquine and mefloquine derivatives against Echinococcus multilocularis","volume":"8","author":"Rufener","year":"2018","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"B33","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1128\/AAC.36.1.191","article-title":"Effects of multiple doses of isoprinosine on Echinococcus multilocularis metacestodes","volume":"36","author":"Sarciron","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"B34","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2174\/1386207318666150305154913","article-title":"Recent progress in the identification and development of anti-malarial agents using virtual screening based approaches","volume":"18","author":"Shah","year":"2015","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e0006422","DOI":"10.1371\/journal.pntd.0006422","article-title":"Progress in the pharmacological treatment of human cystic and alveolar echinococcosis: compounds and therapeutic targets","volume":"12","author":"Siles-Lucas","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2174\/156802610790232260","article-title":"3D-QSAR in drug design\u2013a review","volume":"10","author":"Verma","year":"2010","journal-title":"Curr. Top. Med. Chem."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e725","DOI":"10.7717\/peerj.725","article-title":"DrugOn: a fully integrated pharmacophore modeling and structure optimization toolkit","volume":"3","author":"Vlachakis","year":"2015","journal-title":"Peer J."},{"key":"B39","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1080\/1062936X.2016.1189959","article-title":"Identification of novel PfDHODH inhibitors as antimalarial agents via pharmacophore-based virtual screening followed by molecular docking and in vivo antimalarial activity","volume":"27","author":"Vyas","year":"2016","journal-title":"SAR QSAR Environ. Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.drudis.2007.12.002","article-title":"Towards improving compound selection in structure-based virtual screening","volume":"13","author":"Waszkowycz","year":"2008","journal-title":"Drug Discov. Today"},{"key":"B41","volume-title":"Sustaning the Drive to Overcome the Global Impact of Neglected Tropical Diseases: Second WHO Report on Neglected Tropical Diseases","year":"2013"},{"key":"B42","doi-asserted-by":"publisher","first-page":"4806","DOI":"10.1016\/j.bmcl.2013.06.099","article-title":"Semisynthesis and quantitative structure-activity relationship (QSAR) study of some cholesterol-based hydrazone derivatives as insecticidal agents","volume":"23","author":"Yang","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.bmc.2011.12.035","article-title":"Identification of Trypanosoma brucei leucyl-tRNA synthetase inhibitors by pharmacophore- and docking-based virtual screening and synthesis","volume":"20","author":"Zhao","year":"2012","journal-title":"Bioorg. Med. Chem."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2020.00118\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T04:49:34Z","timestamp":1584679774000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2020.00118\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,20]]},"references-count":43,"alternative-id":["10.3389\/fcimb.2020.00118"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2020.00118","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,20]]},"article-number":"118"}}